Alexander Varshavsky is a Russian-American biochemist, noted for his discovery of the N-end rule of ubiquitination. He is currently researching at Caltech.
Alexander Varshavsky provided an original approach to killing cancer cells, proffered the idea of a targeted molecular device that could enter a cell, examine it for DNA deletions specific to cancer and killing it if it meets the right profile. "(It) involves, in a nutshell, the finding of a genuine Achilles Heel of cancer cells, i.e., their potentially vulnerable feature that won't change during tumor progression," said Varshavsky.
The approach termed deletion-specific targeting (DST), employs HDs (homozygous DNA deletions) as the targets of cancer therapy. "In contrast to other attributes of cancer cells, their HDs are immutable markers." "If the DST strategy can be implemented in a clinical setting, it may prove to be both curative and free of side effects."
Recipient of the Albert Lasker Award for Basic Medical Research, the Wolf Prize in Medicine and the Louisa Gross Horwitz Prize from Columbia University in 2001 for his research on ubiquitination
In 2006 he won the March of Dimes Prize in Developmental Biology and he won the 2007 $1 million Gotham Prize for an original approach to killing cancer cells.
| Year | Prize | Citation |
|---|---|---|
| 2000 | Albert Lasker Award for Basic Medical Research | Ubiquitination |
| 2001 | Wolf Prize in Medicine | Ubiquitination |
| 2001 | Louisa Gross Horwitz Prize | Ubiquitination |
| 2006 | March of Dimes Prize in Developmental Biology | Killing cancer cells |
| 2007 | Gotham Prize | Killing cancer cells |
| 2012 | King Faisal International Prize |
|
||||||||
| This article about an American biochemist is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)